Home › Funds › Aldebaran Capital, LLC › TECX
Aldebaran Capital, LLC position in TECX
TECTONIC THERAPEUTIC INC · Health Care
Aldebaran Capital, LLC reported holding 36,220 shares of TECX (TECTONIC THERAPEUTIC INC) in its Q3 2026 13F filing — a position valued at US$844K, representing 0.61% of its reported portfolio and ranking #29 among its reported holdings. Aldebaran Capital, LLC has disclosed TECX holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Aldebaran Capital, LLC's TECX position evolved
Aldebaran Capital, LLC first disclosed a stake in TECX in Q2 2024 at 41,991 shares (US$692K). The position peaked in Q4 2024 at 41,207 shares, worth US$1.9M. Across 10 filings, Aldebaran Capital, LLC increased the stake 0 time(s), trimmed it 7 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 36,220 shares valued at US$844K — a reduction of -577 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 41.99K | $691.59K | New |
| Q3 2024 | 41.99K | $1.27M | Hold |
| Q4 2024 | 41.21K | $1.90M | Reduce |
| Q1 2025 | 40.90K | $724.27K | Reduce |
| Q2 2025 | 40.26K | $799.93K | Reduce |
| Q3 2025 | 38.50K | $604.10K | Reduce |
| Q4 2025 | 37.35K | $779.18K | Reduce |
| Q1 2026 | 37.18K | $1.15M | Hold |
| Q2 2026 | 36.80K | $1.26M | Reduce |
| Q3 2026 | 36.22K | $843.56K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TECX and 13F data
TECX (TECTONIC THERAPEUTIC INC) is a Health Care company. 48 other funds we track also report a position in TECX — the largest reported positions include TCG Crossover Management, LLC (US$41.4M), First Light Asset Management, LLC (US$27.5M), 5AM Venture Management, LLC (US$20.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TECX
- TCG Crossover Management, LLC 1.20M sh · $41.42M · Q2 2026
- First Light Asset Management, LLC 800.73K sh · $27.52M · Q2 2026
- 5AM Venture Management, LLC 606.66K sh · $20.85M · Q2 2026
- BRAIDWELL LP 596.90K sh · $20.52M · Q2 2026
- Vestal Point Capital, LP 425.00K sh · $14.61M · Q2 2026
- Ikarian Capital, LLC 205.84K sh · $7.08M · Q2 2026
- SECTORAL ASSET MANAGEMENT INC 72.59K sh · $1.69M · Q3 2026
- Tetragon Partners GP Ltd 46.52K sh · $1.60M · Q2 2026
- Prosight Management, LP 39.73K sh · $1.37M · Q2 2026
More on Aldebaran Capital, LLC
FAQ
How long has Aldebaran Capital, LLC held TECX?
Aldebaran Capital, LLC has disclosed TECX holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is Aldebaran Capital, LLC's current position in TECX?
As of Q3 2026, Aldebaran Capital, LLC holds 36.22K shares of TECX (TECTONIC THERAPEUTIC INC), valued at $843.56K, representing 0.61% of its reported portfolio and ranking #29.
Has Aldebaran Capital, LLC been buying or selling TECX?
In the latest 13F filing (Q3 2026), Aldebaran Capital, LLC reduced its position in TECX. The position peaked in Q4 2024 at 41.21K shares.
Which other funds hold TECX?
Other major institutional holders of TECX include TCG Crossover Management, LLC, First Light Asset Management, LLC, 5AM Venture Management, LLC, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.